{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:36:22Z","timestamp":1785814582369,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejogrb.2022.08.012","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T22:50:12Z","timestamp":1661295012000},"page":"84-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review"],"prefix":"10.1016","volume":"277","author":[{"given":"Ottavia","family":"D'Oria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Buzzaccarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Frega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Vizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Caserta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejogrb.2022.08.012_b0005","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.08.012_b0010","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014: Cancer Treatment and Survivorship Statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.08.012_b0015","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/13697137.2021.1898580","article-title":"Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review","volume":"24","author":"Buzzaccarini","year":"2021","journal-title":"Climacteric"},{"key":"10.1016\/j.ejogrb.2022.08.012_b0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2017.12.015","article-title":"Preliminary results of a single-arm pilot study to assess the safety and efficacy of visnadine, prenylflavonoids and bovine colostrum in postmenopausal sexually active women affected by vulvovaginal atrophy","volume":"109","author":"Lagan\u00e0","year":"2018","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.08.012_b0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.23736\/S2724-606X.20.04635-3","article-title":"Urinary incontinence in women: state of the art and medical treatment","volume":"73","author":"Monti","year":"2021","journal-title":"Minerva Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.08.012_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.23736\/S0026-4784.18.04305-8","article-title":"Effectiveness, quality of life and sexual functions in women with anterior compartment prolapse treated by native tissue repair","volume":"71","author":"Monti","year":"2019","journal-title":"Minerva Ginecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.08.012_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/09513590.2018.1500534","article-title":"Usefulness of Ospemifene in the treatment of urgency in menopausal patients affected by mixed urinary incontinence underwent mid-urethral slings surgery","volume":"35","author":"Schiavi","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.08.012_b0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/SPV.0000000000000560","article-title":"Orally Administered Combination of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin in the Prevention of Postcoital Recurrent Urinary Tract Infections: Analysis of 98 Women in Reproductive Age After 6 Months of Treatment","volume":"25","author":"Schiavi","year":"2019","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.ejogrb.2022.08.012_b0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.maturitas.2020.02.009","article-title":"Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study","volume":"135","author":"Di Donato","year":"2020","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.08.012_b0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.23736\/S2724-606X.20.04612-2","article-title":"Non-invasive treatment of vulvovaginal atrophy in menopause with CO2 laser","volume":"73","author":"D\u2019oria","year":"2021","journal-title":"Minerva Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ejogrb.2022.08.012_b0055","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/GME.0000000000000672","article-title":"Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and\/or hormonal therapy for breast cancer: a retrospective study","volume":"23","author":"Pagano","year":"2016","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.08.012_b0060","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","article-title":"Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors","volume":"294","author":"Pieralli","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.08.012_b0065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/GME.0000000000001053","article-title":"Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study","volume":"25","author":"Pagano","year":"2018","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.08.012_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-019-05384-9","article-title":"Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study","volume":"178","author":"Pearson","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.ejogrb.2022.08.012_b0075","first-page":"3669","article-title":"Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors","volume":"28","author":"Quick","year":"2020","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.08.012_b0080","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.anplas.2020.05.002","article-title":"Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial","volume":"65","author":"Hersant","year":"2020","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1016\/j.ejogrb.2022.08.012_b0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2018.02.005","article-title":"Hormone replacement therapy in cancer survivors: Utopia?","volume":"124","author":"Angioli","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejogrb.2022.08.012_b0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2020.10.018","article-title":"Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors","volume":"144","author":"Quick","year":"2021","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.08.012_b0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/tbj.14211","article-title":"Fractional CO\u2082 vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors","volume":"27","author":"Siliquini","year":"2021","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.08.012_b0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/lsm.22637","article-title":"Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies","volume":"49","author":"Tadir","year":"2017","journal-title":"Lasers Surg Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.08.012_b0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.08.012_b0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10103-014-1677-2","article-title":"Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment","volume":"30","author":"Zerbinati","year":"2015","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.ejogrb.2022.08.012_b0115","doi-asserted-by":"crossref","unstructured":"Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U. Sexual function after fractional microablative CO\u2082 laser in women with vulvovaginal atrophy. Climacteric. 2015 Apr;18(2):219-25. doi:10.3109\/13697137.2014.975197. Epub 2014 Dec 16.","DOI":"10.3109\/13697137.2014.975197"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.08.012_b0120","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy","volume":"13","author":"Sturdee","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.ejogrb.2022.08.012_b0125","doi-asserted-by":"crossref","unstructured":"Collaborative Group On Epidemiological Studies Of Ovarian Cancer, Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet. 2015 May 9;385(9980):1835-42. doi:10.1016\/S0140-6736(14)61687-1. Epub 2015 Feb 13.","DOI":"10.1016\/S0140-6736(14)61687-1"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.08.012_b0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2014.12.006","article-title":"Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser","volume":"80","author":"Perino","year":"2015","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.08.012_b0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1634\/theoncologist.11-2-96","article-title":"The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors","volume":"11","author":"Knobf","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.ejogrb.2022.08.012_b0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.maturitas.2020.08.010","article-title":"Genitourinary Syndrome of Menopause: Current Treatment Options in Breast Cancer Survivors - Systematic Review","volume":"143","author":"Mension","year":"2021","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.08.012_b0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/13697137.2019.1646720","article-title":"A study protocol of vaginal laser therapy in gynecological cancer survivors","volume":"23","author":"Athanasiou","year":"2020","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.08.012_b0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10549-021-06226-3","article-title":"Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up","volume":"188","author":"Veron","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.08.012_b0155","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1016\/j.clbc.2021.01.006","article-title":"Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up","volume":"21","author":"Salvatore","year":"2021","journal-title":"Clin Breast Cancer"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152200478X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152200478X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:57:49Z","timestamp":1759557469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121152200478X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":31,"alternative-id":["S030121152200478X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.08.012","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}